Cell Biotech Co ., Limited. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cell Biotech Co ., Limited. with three other
companies in this sector in South Korea:
Choong Ang Vaccine Laboratory
sales of 33.15 billion Korean Won [US$27.85 million]
of which 100%
was Animal Health Product),
G-treeBNT Co Ltd
(46.36 billion Korean Won [US$38.94 million]
of which 61%
was Medicine), and
Komipharm International Company Limited
(34.99 billion Korean Won [US$29.40 million]
of which 96%
was Finished Goods).
Cell Biotech Co ., Limited. reported sales of 62.54 billion Korean Won (US$52.54 million)
December of 2018.
increase of 2.4%
versus 2017, when the company's sales were 61.06 billion Korean Won.
Sales at Cell Biotech Co ., Limited. have increased during each of the previous five years
(and since 2013, sales have increased a total of 98%).
Sales of Finished Products saw an increase
2.8% in 2018, from
53.97 billion Korean Won to 55.51 billion Korean Won.
Not all segments of Cell Biotech Co ., Limited. experienced an increase in sales in 2018:
sales of Raw Material fell 0.7% to 7.03 billion Korean Won.